caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1275505000

Robert OatesM.D.

UrologyBoston, MAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 220031
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
56
Beneficiaries
—
Total drug cost
$9K
Distinct drugs
3
Brand share
30.4%
Top prescribed drugs
Tamsulosin Hcl27 claims
Mirabegron17 claims
Terazosin Hcl12 claims
REFERRAL NETWORK

Where Robert Oates's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 2 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BOSTON MEDICAL CENTER CORPORATION59294
Jaime Silva
Physician Assistant · Boston, MA
1516
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
BOSTON MEDICAL CENTER CORPORATION101516
BOSTON MEDICAL CENTER CORPORATION1136
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
24
Unique beneficiaries
—
Total services
24
Distinct HCPCS
1
Medicare payment
$1K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 244 Urology providers in MA — bottom quintile (cohort median 2,012).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.